400
Participants
Start Date
May 14, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
June 30, 2029
Follow up if MRI is negative
Enter the follow-up cohort without systematic biopsy when prostate cancer is clinically suspected and no PIRADS v2.1 score ≥3 lesions are detected on initial examination. MR plus regional saturation biopsy was performed when MRI progressed.
Systematic biopsy if MRI is negative
Systematic biopsy was performed if there was clinical suspicion of prostate cancer and no PIRADS v2.1 score ≥3 lesions were detected on initial examination. If the biopsy was negative enter the follow-up cohort.
Peking University First Hospital, Beijing
Peking University First Hospital
OTHER